ORG Partners’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History

ORG Partners’s Portfolio MDNA Stock Details MDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-175,000	Closed	-$200K	–	1635
2024 Q4	$200K	Buy	175,000 +50,000	+40%	+$57.3K	0.03%	320
2024 Q3	$175K	Buy	125,000 +25,000	+25%	+$35K	0.03%	302
2024 Q2	$145K	Buy	+100,000	New	+$145K	0.02%	495

ORG Partners's MDNA Position: Q1 2025 in Review

ORG Partners sold out of Medicenna Therapeutics Corp. Common Shares (MDNA) in Q1 2025, closing a stake of 175,000 shares — an estimated $200K sold.

ORG Partners first reported a position in MDNA in Q2 2024 and held it in 3 quarters. The position peaked at $200K in Q4 2024. 0 funds tracked by Wall St. Rank hold MDNA as of Q1 2025.

ORG Partners reported no remaining Medicenna Therapeutics Corp. Common Shares position as of Q1 2025 after selling out during the quarter.
ORG Partners sold 175,000 Medicenna Therapeutics Corp. Common Shares shares in Q1 2025, an estimated $200K.
ORG Partners first reported a position in Medicenna Therapeutics Corp. Common Shares in Q2 2024 and held it in 3 quarters.
ORG Partners's Medicenna Therapeutics Corp. Common Shares position peaked at $200K in Q4 2024.
0 funds tracked by Wall St. Rank held Medicenna Therapeutics Corp. Common Shares as of Q1 2025.

Based on ORG Partners's 13F filing for Q1 2025, filed 21 Apr 2025.